The nuMom2b study – short for “Nulliparous* Pregnancy Outcomes Study: Monitoring Mothers-To-Be” – is a prospective study that enrolled over 10,000 first time pregnant women across the United States and followed them through their pregnancies and after delivery. In this study, researchers used the wellness data collected in nuMom2b to study how wellness related to risk for a hypertensive disorder of pregnancy (HDP). Wellness data included information about their nutrition, exercise, illnesses, and sleep. The study results showed that patients reporting higher vegetable consumption in the first trimester, as well as more exercise in the second and third trimesters had decreased risk for an HDP. Also more sleep combined with exercise in the third trimester also decreased HDP risk. Identifying the healthful behaviors that lower the risk for a hypertensive disorder of pregnancy can help develop recommendations and prevention programs to support lowering pregnant women’s risk for developing an HDP.
*Nulliparous = a female of reproductive age who has never had a live delivery
Link: https://pubmed.ncbi.nlm.nih.gov/36959650/
Citation: Mollard E, Cottrell C. Lifestyle and the hypertensive disorders of pregnancy in nulliparous women in the United States: a secondary data analysis of the nuMom2b. BMC Pregnancy Childbirth. 2023 Mar 23;23(1):201. doi: 10.1186/s12884-023-05522-8. PMID: 36959650; PMCID: PMC10035211.
Each quarter, our team of science writers reviews the most current research studies related to hypertensive disorders of pregnancy and summarizes those studies of greatest interest and potential impact to our community, including research studies related to risk assessment, diagnosis, prevention, and treatment. Special thanks to our volunteer research team, who under the leadership of Dr. Elizabeth Sutton, make Research Roundup possible and to our Patient Advisory Council, who reviews these materials from the patient perspective.
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
Long-term neurodevelopmental follow-up of children exposed to pravastatin in utero If given in early pregnancy pravastatin, (a drug used to lower cholesterol) may decrease the risk of developing pree...
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy (a rat model) Currently the only treatment for preeclampsia starts with delivery of the baby and the placenta....
Current Status and Prospects of the Single-Cell Sequencing Technologies for Revealing the Pathogenesis of Pregnancy-Associated Disorders The adult human body is made up of about 100 trillion cells. I...
First-Trimester Screening for HELLP Syndrome—Prediction Model Based on MicroRNA Biomarkers and Maternal Clinical Characteristics Hypertensive disorders of pregnancy and cardiovascular disease a...
First Trimester Preterm Preeclampsia Prediction with Metabolite Biomarkers: Differential Prediction According to Maternal Body Mass Index Recent research suggests that there may be different types of...